Immunome
-
Neither the Pandemic Nor Labor Shortages Could Mute Phila.’s 2021 Venture Capital Boom
Despite the disruptions caused by the coronavirus pandemic and labor shortages, Philadelphia experienced a venture capital boom in 2021, write Taylor Allen and Mike D’Onofrio…
-
With Omicron Variant Now in the U.S., Could Exton-Based Immunome’s ‘Antibody Cocktail’ Be the Neutralizer?
Exton-based Immunome has submitted an application with the FDA to start human testing its “antibody cocktail” as a potential COVID-19 treatment, writes John George for…
Founding Partners
Advertisement
Affiliate Partners
